Logo image of AIL.DE

AIR LIQUIDE SA (AIL.DE) Stock Fundamental Analysis

Europe - FRA:AIL - FR0000120073 - Common Stock

172.78 EUR
-1.26 (-0.72%)
Last: 10/17/2025, 7:00:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to AIL. AIL was compared to 69 industry peers in the Chemicals industry. While AIL has a great profitability rating, there are some minor concerns on its financial health. While showing a medium growth rate, AIL is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year AIL was profitable.
In the past year AIL had a positive cash flow from operations.
Each year in the past 5 years AIL has been profitable.
Each year in the past 5 years AIL had a positive operating cash flow.
AIL.DE Yearly Net Income VS EBIT VS OCF VS FCFAIL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

1.2 Ratios

The Return On Assets of AIL (6.70%) is better than 76.81% of its industry peers.
AIL's Return On Equity of 13.49% is fine compared to the rest of the industry. AIL outperforms 75.36% of its industry peers.
AIL has a Return On Invested Capital of 9.87%. This is amongst the best in the industry. AIL outperforms 84.06% of its industry peers.
AIL had an Average Return On Invested Capital over the past 3 years of 9.47%. This is above the industry average of 7.19%.
The 3 year average ROIC (9.47%) for AIL is below the current ROIC(9.87%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.7%
ROE 13.49%
ROIC 9.87%
ROA(3y)6.1%
ROA(5y)5.92%
ROE(3y)12.2%
ROE(5y)12.34%
ROIC(3y)9.47%
ROIC(5y)8.98%
AIL.DE Yearly ROA, ROE, ROICAIL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10

1.3 Margins

Looking at the Profit Margin, with a value of 12.22%, AIL belongs to the top of the industry, outperforming 88.41% of the companies in the same industry.
AIL's Profit Margin has improved in the last couple of years.
AIL has a Operating Margin of 19.93%. This is amongst the best in the industry. AIL outperforms 94.20% of its industry peers.
In the last couple of years the Operating Margin of AIL has grown nicely.
The Gross Margin of AIL (63.01%) is better than 92.75% of its industry peers.
In the last couple of years the Gross Margin of AIL has remained more or less at the same level.
Industry RankSector Rank
OM 19.93%
PM (TTM) 12.22%
GM 63.01%
OM growth 3Y3.78%
OM growth 5Y2.86%
PM growth 3Y3.49%
PM growth 5Y3.63%
GM growth 3Y1.78%
GM growth 5Y0.07%
AIL.DE Yearly Profit, Operating, Gross MarginsAIL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so AIL is still creating some value.
Compared to 1 year ago, AIL has about the same amount of shares outstanding.
The number of shares outstanding for AIL has been increased compared to 5 years ago.
The debt/assets ratio for AIL has been reduced compared to a year ago.
AIL.DE Yearly Shares OutstandingAIL.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
AIL.DE Yearly Total Debt VS Total AssetsAIL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.2 Solvency

AIL has an Altman-Z score of 3.86. This indicates that AIL is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.86, AIL is in the better half of the industry, outperforming 79.71% of the companies in the same industry.
AIL has a debt to FCF ratio of 4.60. This is a neutral value as AIL would need 4.60 years to pay back of all of its debts.
AIL's Debt to FCF ratio of 4.60 is fine compared to the rest of the industry. AIL outperforms 79.71% of its industry peers.
A Debt/Equity ratio of 0.47 indicates that AIL is not too dependend on debt financing.
AIL has a Debt to Equity ratio (0.47) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 4.6
Altman-Z 3.86
ROIC/WACC1.34
WACC7.36%
AIL.DE Yearly LT Debt VS Equity VS FCFAIL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.3 Liquidity

A Current Ratio of 0.84 indicates that AIL may have some problems paying its short term obligations.
AIL has a Current ratio of 0.84. This is amonst the worse of the industry: AIL underperforms 88.41% of its industry peers.
AIL has a Quick Ratio of 0.84. This is a bad value and indicates that AIL is not financially healthy enough and could expect problems in meeting its short term obligations.
AIL's Quick ratio of 0.61 is on the low side compared to the rest of the industry. AIL is outperformed by 86.96% of its industry peers.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.61
AIL.DE Yearly Current Assets VS Current LiabilitesAIL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

4

3. Growth

3.1 Past

AIL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.10%, which is quite good.
The Earnings Per Share has been growing by 11.55% on average over the past years. This is quite good.
The Revenue has decreased by -1.99% in the past year.
AIL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.30% yearly.
EPS 1Y (TTM)11.1%
EPS 3Y12.6%
EPS 5Y11.55%
EPS Q2Q%-4.88%
Revenue 1Y (TTM)-1.99%
Revenue growth 3Y5.06%
Revenue growth 5Y4.3%
Sales Q2Q%2.94%

3.2 Future

The Earnings Per Share is expected to grow by 10.00% on average over the next years. This is quite good.
Based on estimates for the next years, AIL will show a small growth in Revenue. The Revenue will grow by 4.18% on average per year.
EPS Next Y5.18%
EPS Next 2Y8.76%
EPS Next 3Y9.11%
EPS Next 5Y10%
Revenue Next Year0.67%
Revenue Next 2Y2.65%
Revenue Next 3Y3.56%
Revenue Next 5Y4.18%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
AIL.DE Yearly Revenue VS EstimatesAIL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B
AIL.DE Yearly EPS VS EstimatesAIL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 27.56 indicates a quite expensive valuation of AIL.
The rest of the industry has a similar Price/Earnings ratio as AIL.
When comparing the Price/Earnings ratio of AIL to the average of the S&P500 Index (27.40), we can say AIL is valued inline with the index average.
A Price/Forward Earnings ratio of 22.72 indicates a rather expensive valuation of AIL.
AIL's Price/Forward Earnings ratio is in line with the industry average.
AIL is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.94, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 27.56
Fwd PE 22.72
AIL.DE Price Earnings VS Forward Price EarningsAIL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

AIL's Enterprise Value to EBITDA is on the same level as the industry average.
AIL's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. AIL is cheaper than 60.87% of the companies in the same industry.
Industry RankSector Rank
P/FCF 36.35
EV/EBITDA 13.8
AIL.DE Per share dataAIL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AIL does not grow enough to justify the current Price/Earnings ratio.
AIL has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)5.32
PEG (5Y)2.39
EPS Next 2Y8.76%
EPS Next 3Y9.11%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.92%, AIL has a reasonable but not impressive dividend return.
AIL's Dividend Yield is comparable with the industry average which is at 3.22.
Compared to an average S&P500 Dividend Yield of 2.38, AIL has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.92%

5.2 History

The dividend of AIL has a limited annual growth rate of 5.86%.
Dividend Growth(5Y)5.86%
Div Incr Years6
Div Non Decr Years6
AIL.DE Yearly Dividends per shareAIL.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

59.10% of the earnings are spent on dividend by AIL. This is a bit on the high side, but may be sustainable.
The dividend of AIL is growing, but earnings are growing more, so the dividend growth is sustainable.
DP59.1%
EPS Next 2Y8.76%
EPS Next 3Y9.11%
AIL.DE Yearly Income VS Free CF VS DividendAIL.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
AIL.DE Dividend Payout.AIL.DE Dividend Payout, showing the Payout Ratio.AIL.DE Dividend Payout.PayoutRetained Earnings

AIR LIQUIDE SA

FRA:AIL (10/17/2025, 7:00:00 PM)

172.78

-1.26 (-0.72%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-29 2025-07-29/bmo
Earnings (Next)10-21 2025-10-21
Inst Owners28.16%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap99.95B
Analysts80
Price Target202.17 (17.01%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.92%
Yearly Dividend2.98
Dividend Growth(5Y)5.86%
DP59.1%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.89%
PT rev (3m)1.68%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.6%
EPS NY rev (3m)-4.3%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.22%
Revenue NY rev (3m)-2.91%
Valuation
Industry RankSector Rank
PE 27.56
Fwd PE 22.72
P/S 3.69
P/FCF 36.35
P/OCF 15.49
P/B 4.08
P/tB 10.93
EV/EBITDA 13.8
EPS(TTM)6.27
EY3.63%
EPS(NY)7.61
Fwd EY4.4%
FCF(TTM)4.75
FCFY2.75%
OCF(TTM)11.16
OCFY6.46%
SpS46.77
BVpS42.38
TBVpS15.81
PEG (NY)5.32
PEG (5Y)2.39
Profitability
Industry RankSector Rank
ROA 6.7%
ROE 13.49%
ROCE 13.55%
ROIC 9.87%
ROICexc 10.27%
ROICexgc 16.67%
OM 19.93%
PM (TTM) 12.22%
GM 63.01%
FCFM 10.16%
ROA(3y)6.1%
ROA(5y)5.92%
ROE(3y)12.2%
ROE(5y)12.34%
ROIC(3y)9.47%
ROIC(5y)8.98%
ROICexc(3y)9.91%
ROICexc(5y)9.43%
ROICexgc(3y)16.92%
ROICexgc(5y)16.28%
ROCE(3y)12.5%
ROCE(5y)11.85%
ROICexcg growth 3Y3.94%
ROICexcg growth 5Y3.85%
ROICexc growth 3Y4.91%
ROICexc growth 5Y4.63%
OM growth 3Y3.78%
OM growth 5Y2.86%
PM growth 3Y3.49%
PM growth 5Y3.63%
GM growth 3Y1.78%
GM growth 5Y0.07%
F-Score7
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 4.6
Debt/EBITDA 1.45
Cap/Depr 144.44%
Cap/Sales 13.69%
Interest Coverage 20.74
Cash Conversion 81.12%
Profit Quality 83.16%
Current Ratio 0.84
Quick Ratio 0.61
Altman-Z 3.86
F-Score7
WACC7.36%
ROIC/WACC1.34
Cap/Depr(3y)136.72%
Cap/Depr(5y)133.49%
Cap/Sales(3y)12.08%
Cap/Sales(5y)12.32%
Profit Quality(3y)89.93%
Profit Quality(5y)95.75%
High Growth Momentum
Growth
EPS 1Y (TTM)11.1%
EPS 3Y12.6%
EPS 5Y11.55%
EPS Q2Q%-4.88%
EPS Next Y5.18%
EPS Next 2Y8.76%
EPS Next 3Y9.11%
EPS Next 5Y10%
Revenue 1Y (TTM)-1.99%
Revenue growth 3Y5.06%
Revenue growth 5Y4.3%
Sales Q2Q%2.94%
Revenue Next Year0.67%
Revenue Next 2Y2.65%
Revenue Next 3Y3.56%
Revenue Next 5Y4.18%
EBIT growth 1Y6.38%
EBIT growth 3Y9.02%
EBIT growth 5Y7.28%
EBIT Next Year55.91%
EBIT Next 3Y21.96%
EBIT Next 5Y16.07%
FCF growth 1Y-11.78%
FCF growth 3Y1.77%
FCF growth 5Y6.15%
OCF growth 1Y-1.15%
OCF growth 3Y4.31%
OCF growth 5Y6.05%